Direct selective oxidation afforded the sulfoxides of deaminc-Ivcarba-oxytocin (Ia), deamino--ti-carba-oxytocin (Ie), and Lcarba-oxytocin (Id). The sulfoxide Ia was also prepared by a stepwise synthesis of the peptide chain. For purposes of comparison, the sulfone of deamino-l-carba--oxytocin (Ib) was prepared. The pharmacological properties ofcompounds Ia-Idwere examined. Of a special interest is the difference in activities of sulfoxidee of the l-carba and ti-carba series and dissociation of effects on uterus and lactation. With the use of model compounds, the reduction of suIfoxides was examined and the most advantageous procedure (hydrogen bromide/acetone) was applied to the sulfoxide Ia which afforded the sulfide Ie without formation of by-products.
Sulfoxidcs of Carba-Analogues of Oxytocin 1539
The sulfide can be converted to the sulfoxide by several procedurea'P from which, however, only a few are suitable for the present field of substances. The procedure of choice must afford selectively the sulfoxide, the reaction conditions must be mild, and the reaction must be as fast as possible. Analogous requirements apply to reduction of the sulfoxide.
As a model substance in investigations on the oxidation of sulfides and reduction of the corresponding sulfoxides, S-(y-methoxycarhonylpropyl)cysteine 3 (IVa) was used, i.e., the parent amino acid of the so-called l-carba-analogues of neurohypophyseal hormones. Oxidation with hydrogen peroxide in acid and neutral media was examined. The sulfone VI a is quantitatively formed in acid media whereas a slow oxidation to the sulfoxide Va occurs in neutral media. Twenty four bours at room temperature are required for a complete conversion. When compared with cystathionine'? and the thialysine derivatives! B, the present reaction is more specific. In the case of cystathionine, the formation of the sulfoxide was observed' 9 even in acid media under vigorous conditions. A similar behaviour was also reported for the case of methionine-? which affords a pure sulfoxide by the action of excess hydrogen peroxide inIM-HCI. When the oxidation is performed with performic acid, the results are analogous to those obtained in the case of Svmethylcysteinej' (II). At room temperature, the sulfone VIa is exclusively obtained whereas at -15°C, a mixture of the snlfone VI a and the sulfoxide Va is formed. Like the German anthors' 8 working on thialysine derivatives, we did not succeed in preparing a pure sulfoxide by the action of bromiue. Best results were obtained with the use of the periodate as oxidanr'" (this reagent has not been as yet used in the oxidation of amino acids). The reaction is fast enough and the first order reaction coustantequals to 1·1 .10-3 • s-· at 22'C. The use of excess reageut and prolonged reaction time does not result in the formation of the sulfone. The conversion of the sulfide is quantitative after 2 h; after additional 200 h, uo sulfone was detected by chromatography. The advantage of potassium periodate consists in its low solubility in water and the great solubility of the iodate as tbe reaction product (in spite of excess reagent, the reaction takes place in an excess of the oxidized component). Sodium periodate is much more soluble in water and its reduction product, sodium iodate, can be precipitated with methanol after completion of the oxidation.
Interesting results may be observed in the acid hydrolysis (6M-HCl, 105'C under diminished pressure) of the sulfoxide Va. Irrespective of the reaction time, the hydrolysis of the sulfoxide (either free or as component of a peptide chain) affords S-(y-carboxypropyl)cysteine (Vb) in 50% yield. A similar behaviour may be observed in the case of S-(J3-melhoxycarbonylethyl)homocysteine sulfoxide (VIII) and cystathionine sulfoxide as components of the peptide. Such a behaviour was also reported in the case of S-methylcysteine sulfoxidef! (III) but was not quantitatively evalnated.
Under analogous conditions, methionine sulfoxide affords methionine in high yield ducts in which cysteine predominatesf". Contrary to S-carboxymethylcysteine sulfone 21 , the sulfones VIa and IX and S-methylcysteine sulfone do not decompose (only the methyl ester is hydrolysed); we may thus exclude explanation of the 50% recovery of the sulfide from the sulfoxide Va by means of a disproportionation to the sulfide IV and the sulfone VI followed by decomposition of the sulfone with the formation of ninhydrin-negative substances. It was not possible to exclude a priori another mechanism consisting in the decomposition of the sulfoxide Va to a sulfenic acid derivarlve'" (and dehydroalanine which is converted to pyruvic acid); the sulfenic acid derivative would make possible reduction of the other portion of the sulfoxide Va to the corresponding sulfide. However, in the case of the sulfoxide VIII such an explanation based on a partial reduction is not as evident since the yield of S-(p-carboxyethyl)homocysteine VIIb in the hydrolysis of the sulfoxide VIII was 20% in the case of the free amino acid and 54%in the case of the peptide Ic. By the formation of a snlfoxide and its snbseqnent 50% destruction it is possible to explain the low values of S-(y-carboxypropyl)cysteine (IVb) in the amino-acid analysis and to determine in this manner the content of the sulfoxide V in the peptide. The hydrolysis of the substance is performed in a properly evacuated (10 min) and sealed ampoule since in the case of an incomplete evacuation or when the evacuation is omitted, the yield of the amino acid is as low as 70%. When the hydrolysis is performed in the presence of an oxidant (NaIO4), the recovery of the sulfide I Vb is not recorded and the hydrolysate contains the original sulfoxide Vb (in the form of a diacid]; such a result does not correspond to the above proposed mechanism.
From circnlar dichroism curves of the present sulfoxides, the absolute configuration on sulfur of the predominant diastereoisomer was determined as R (ref. 24 ) . In the periodate oxidation of S-(y-methoxycarbonylpropyl)cysteine (IVa), the ratio of the resulting diastereoisomers is 54 : 46; in the oxidation with hydrogen peroxide, the ratio is 57 : 43. These diastereoisomeric sulfoxides may be separated by paper chromatography and ion exchange chromatography under conditions of an analysis in amino-acid analyser, see Table I and II. The separation by ion exchange chromatography is also successful in the case of diastereoisomeric sulfoxides VIII but fails with diastereoisomers of S-methylcysteine sulfoxide (III). In the preparation of sulfoxides of carba-analogues of oxytocin, the sodium periodate oxidation was used as the procedure of choice. After two hours, the excess oxidant and the corresponding iodate were removed by gel filtration and the product was freeze-dried. This procedure was used in the preparation of sulfoxides I a, I c, and Id derived from deamino-J-carba-oxytocin, deamino-S-carba-oxytocin, and l-carba-oxytocin, resp. In order to demonstrate that no sulfone is formed from the sulfide in this case, the authentic sulfone Ib of deamino-l-carba-oxytocin was prepared by performic acid oxidation and its chromatographic data were examined. The chromatographic behaviour (Table HI) 
R=H
The amino acid analysis may be successfully applied to prove sulfoxide and sulfone structures. Sulfoxide Ia gives 50% of parent amino acid in the form of sulfide IVb, whereas sulfone of S-(y-carboxypropyl)cysteine(Vlb) remained unchanged. Further-more, the vibrations of -SO-and -S02-gronps can be detected by IR spectroscopy. The spectrum of a model mixture containing 90% of deamino-dicarba-oxytocin (Ill) and 10% of sulfoxide 111 contains a band at 1006 cm-1 of medium intensity, whereas the spectrum of compound 1a has two weak bands in the expected area with frequencies shifted to the greater values. This finding should indicate the intramolecular interaction of sulfoxides with some polar group of the peptide molecule. Such an interaction is demonstrated by splitting the band into a doublet with lower intensity and therefore it is not possible to use IR spectroscopy to detect small amounts of sulfoxides in the analogue synthesized.
Polarography seemed to be promising for detection of sulfoxides". S-Methylcysteine sulfoxide (III) and sulfoxide Va were used as model compound. In the first case no wave attributable to the reduction of sulfoxide was observed and in the other case only a poorly developed wave was detected just before the area of the final current increase. This wave may be attributed to the catalytic wave of hydrogen and it is not therefore possible to Use it for the detection of sulfoxides in the molecules with molecular weights similar to those of neurohypophysial hormones. The Thompson tesr'", which is still the most specific assay, although not quantitative, was used for verifying the newly synthesized sulfoxides.
For completely unambiguous confirmation of the identity of the synthesized analogues the stepwise building up of deamino-f-carba-oxytocin sulfoxide (Ia) was performed. This analogue was selected as a representative of the sulfoxide series because of synthetic procedure reasons and a dissociation of biological activities accompanied by a decrease of biological potencies. Sulfoxide Va was converted by means of Bunte salt 2 7 to N-benzyloxycarbonyl-S-(y-methoxycarbonylpropyl)cysteine sulfoxide, which was obtained in the form of dicyclohexylammonium salt (X). The extremely low yield of this reaction obviously resulted from the intramolecular interaction of the amino group with the sulfoxide that served as protection against acylation. Carbobenzoxylation using benzyloxycarbonyl chloride at higher pH (8·5) gives the desired product X in a good yield. Owing to the fact that partial reduction of sulfoxide of S-benzylcysteine was describedj" when the benzyloxycarbonyl group from the cysteine derivative was split off by hydrogen bromide in acetic acid, we verified whether similar reduction did not occur also in the case of sulfoxide Va. By TLC we found that approximately 5% of sulfide was regenerated and for this reason the procedure was avoided. 
XIVa, X~Nps;
for the further building up of the peptide chain it was necessary to examine whether the sulfoxide group of the molecule would not be influenced when the prolecting group was split off. The stability of sulfoxide was proved by splitting off this group from 2-nitrobenzenesulfenylasparagine in mixture with sulfoxide Va. Peptide XII was prolonged by the 2,4,5-tricWorophenyl ester of 2-nitrobenzenesulfenylasparagine; this resulted in appearance of water soluble pentapeptide XIII. When the protecting group was split off hexapeptide XIVa was prepared using the same active ester of 2-nitrobenzenesulfenylglutamine. This peptide was also soluble in water and part of it was filtered through Arnberlite IR-4B. The protecting group was split off by HCI and the hydrochloride generated was transformed into the free peptide XIVb by filtration through Amberlite IR-4B. Alternatively the oxidation-hydrolytic method/" was applied at this stage for the removal of the 2-nitrobenzenesulfenyl protecting group. This method based on the simultaneous action of sodium periodate and water gave the free peptide in a high yield. The resulting peptide XIVb acylated by the N-hydroxysuccinimide ester of 2-nitrobenzenesulfenyliwleucine gave a poorly water soluble peptide XVa. The amino-protecting group was split off and methylester was hydrolyzed by aqueous sodium hydroxide. Peptide XVb was then acylated by N-hydroxysuccinimide ester of 2-nitrobenzenesulfenyl-O-tert-butyltyrosine. The octapeptide XVI obtained was converted into the active ester by treatment with bis(p-nitrophenyl) sulfite and after the amino-protecting group was split off cyclization was performed in the usual manner'. Then, the protecting group on tyrosine was removed by means of trifluoroacetic acid and the analogue I a thus prepared was purified by counter-current distribution and gel filtration. In the counter-current distribution in the system 2-butanol-0'Oi% aqueous acetic acid, sulfoxide I a had a different distribution coefficient than peptide Ie (K = 1'30 and 2'15, resp.) and it was therefore possible to exclude the contamination of analogue Ie by the product of sulfur oxidation if the final hormone analogue was purified by counter-current distribution. The chromatographic properties of sulfoxide Ia (synthesized or obtaiued by a direct oxidation) differ from those of sulfide Ie into which sulfoxide I a may be converted by reduction. A series of methods for sulfoxide reduction was published 2 ' -31 but only a part of them may be used for our purposes"-'6. We tested the reduction of model compounds (III, Va) by means of 2-chloro-l,3,2-benzodioxaphospho]e 37 (giving a mixture of products) and 2-mercaptoethanoI 2 0 , which turned to be utilisable but due to reaction conditions (50'C, 24 h) not the best one. Considering the reaction conditions the reduction by hydrogen bromide and acetone-? (a procedure described some time ago but rarely used) proved to be best. The mild reaction conditions (20'C, 5 min) are comparable only with dichloroborane reduction." (O'C, several min). It was verified that under the mentioned conditions the tyrosine residue was not damaged and no cleavage of the molecule occurred even at reaction time longer by the magnitude of ten. The yields of the reduction were nearly theoretical when ionex chromatography was used for the product isolation. By the above-mentioned method sulfoxide Ia was reduced giving sulfide Ie with full biological activity; in this case the product was isolated by gel filtration.
LebI, Barth, Jogt :
The biological activities of oxidized monocarba-analogues together with the activities of some reference compounds are presented in Table IV . Compound I a had both the activities tested, i.e. uterotonic in vitro'? and milk-ejectingr", lowered and dearly dissociated. The biological activities of a sample prepared by the oxidation of Ie were approximately same as those found for the sample prepared by the stepwise synthesis. Significantly higher potencies were fonnd for sulfoxide Ie, they represented one half of the values estimated for the corresponding sulfide and this decrease was proportional for both the activities. The oxidation of carba-analogue with maintained amino group led to a decrease of potencies by several magnitudes of ten,just as it was found for the oxidation of deamino-l-carba-oxytocin to the sulfone stage. No inhibitory properties of the compound Ib were observed in the uterotonic assay (ratio Ibjoxytocin, 400: I).
It has been mentioned in many publications that the sulfur atoms of the oxytocin molecule are not equivalent. Differences in biological potencies were found for deamino-f-carba-and deamino-o-cnrba-oxytocinsf'<f just as in the case of monoseleno analogues of deamino-oxytocin", Also the chiroptical properties of monocarba-analogues were differenr':'. The great difference between the activities of I a and Ie showed that non-equivalency of sulfur atoms was more evident when they were oxidized instead of having been replaced by methylene or by a selenium atom. Concerning the biological activities of sulfoxide the general tendency was similar to selena-analogues where compounds of the l-seleno series were more active as compared with 6-seleno-analogues; in our case the analogues possessing sulfoxide group in position I (i.e. analogues of the 6-carba series) had higher activities. Though we did not verify it experimentally, we did not consider it provable that the difference in the activities of compounds Ia and Ie was caused by a different metabolic stability of the analogues during their interaction with receptors or different elimination rates from the receptor compartment. The availableinformation on the oxytocin receptor (uterus) is not sufficient to support fully the correctness of the hypothesis according to which the agent intrudes "the receptor pocket" by a part of disulfide bond belonging to the sulfur atom in position 6 and that sulfoxide derived from this sulfur (i.e. sulfoxide of the l-carba series) cannot attain such a similar "receptor fit" due to spatial reasons. It is more plausible to cousider that the spatial position of the tripeptide side chain is iufluenced by a strongly polar group in position 6. From the proposed secondary structuret" of oxytocin as well as from the measurements of diffusion rates through membranes' s follows that the tripeptide side chain is oriented above the cyclic part of molecule. A priori one cannot exclude the interaction of the sulfoxide in position 6 with this chain, mainly the effect on the hydrogen bond formed by the amino group of glycine and the carbonyl group of cysteine in position 6 which concenquently forces the adoption of a less suitable conformation of the tripeptide side chain in its interaction with the receptor. Taking in account the model of oxytocin proposed by American authors?" for the conformation of hormone in water, it is evident that the oxidized sulfur in position 6 influenced dramatically the above mentioned hydrogen bond whereas the oxidized sulfur in position I was without effect. Sulfoxide in position I could affect the hydrogen bond between the amino-group of cysteine in position I and the carbonyl group of glycine which, however, is excluded in the case of deamino-analogue Ie. Therefore, the oxidation of this sulfur did not have a pronounced effect on the activity of deamino-ti-carba--oxytocin. The significantly lower activity of sulfone Ib could be explained by higher steric requirements ofthe-S0 2 -group or by higher probability of effecting a hydrogen bond between the side-chain and the cyclic part of the molecule, in comparison with sulfoxide I a in which only one of the diastereoisomers could disturb this hydrogen bond (ef.46). We cannot be sure that sulfoxideIa is exclusively of one configuration although measurements of dichroic spectra of model sulfoxides/" show that the configuration of the sulfoxide sulfur changes quite simply and becomes thermodynamically more favorable.
The explanatiou of the extremely lowered activity of sulfoxide I d may be based on the preferential formation of a hydrogen bond between the sulfoxide group and the amino group of cystein in position I (wbich in oxytocin is engaged in a hydrogen bond with the glycine carbonyl) as a result of which not only the conformation of the cyclic part of the molecule is altered but also that of the tripeptide side chain.
EXPERIMENTAL
Samples for elemental analysis were dried for 24 h at room temperature and 1 Torr, Thin-layer chromatography (TLC) was carried out on silica gel plates (Silufol, Kavalier) in the solvent systems: 2-butanol-98% formic acid-water 75: 13-5: 11,5 (Sl), z-butanct-25% ammonia-water Lebl 
with independent shifting of both upper and lower phases, was used. In all cases the solvent system was 2-butanol-0'05% aqueous acetic acid and the peptide material was located by the Folin-Ciocalteau reaction. For gel filtration we used the columns (100 X 1 em) of Bie-gel (Bio-Rad Laboratories) P-2 and P-4.
S-(y-Methoxycarbonylpropyl)cysteine Sulfoxide (Va) a) To the solution of S-(y-methoxycarbonylpropyl)cysteine 3 (IVa) (3'15 g) in water (180 ml) sodium periodate (4 g) was added and the mixture was stirred 2 h at room temperature. After filtration. the mixture was cooled to O°Cand placed on a column of Dowex-Sf (H+ -cycle, 100 ml). The ion exchanger .was washed with water (O°C, negative test for iodate ions) and the product was eluted with 10% pyridine (O°C). The eluate was evaporated and the residue was crystallized from water and acetone; the yield was c) The suspension of IVa (220 mg) in a mixture of water (4'5 ml), methanol (2'5 ml) and 30% H 2 0 2 (0'3 mI) was agitated 1 h at room temperature. The resulting solution contained 45% of sulfoxide Va and 55% of unreacted sulphide IVa. After further 24 h of standing at room temperature the product was precipitated by the addition of acetone; the yield was 190 mg of a compound, rn.p. 131-133°C, containing about 1% of sulfone VIa, d) To the solution of IVa (220 mg} in water (25 mI) 100}.ll of Br 2 was added. After mixing, the colour of the mixture immediately disappeared and pH value became lower. The solution was freeze-dried and the oily product which was obtained, contained the same amount of sulfide IVa and sulfoxide Va (TLC).
e) Compound IVa (220 mg) was suspended in chloroform (25 ml) and the solution obtained after addition of IOO}.lI of Br 2 was evaporated 5 min later, the residue was dissolved in water and freeze dried. The same mixture of compounds was obtained as in the previous attempt.
Hydrochloride of SM(y-Methoxycarbonylpropyl)cysteine Sulfoxide (Va. HC!)
To the solution of sulfoxide Va (237 mg) in methanol (6 ml) 2M-HCI in ether (0'5 ml) was added and the product was precipitated by the addition of ether (40 ml). Crystallisation from methanol and ether yielded 220 mg (81%) of the product with m.p. 126-128°C; [C(]fis 0°(c 0'2, water). For C,H 1 6CIN05S (273'7) calculated: 35·10% C, 5'89% H, 5'12% N; found: 34'89% C, 6·01% H 5'15% N.
S-(y-Carboxypropyl)cysteine Sulfoxide (Vi
To the solution of methyl ester Va (237 mg} in water (2 ml) IM-NaOH (2 ml) was added. After 1 h at room temperature the solution was cooled down to O"C and filtered through the column of Dowex 50 (H +-form, 10 ml). The column was washed with water (O"C) and the product was eluted with 10% pyridine c) To the solution of IVa (220 mg) in a mixture of water (1'5 ml), concentrated hydrochloric acid (0,2 ml) and methanol (Z'5 ml), 10% H 20 Z (0'8 mI) was added. After 1 h at room temperature methanol was evaporated and the mixture was freeze-dried. The yield was 240 mg of hydrochloride VIa, m.p. 146-148°C, chromatographically identical with the compound prepared as under a) above.
•
S-(p-MethoxycarbonylethyI)homocysteine Sulfoxide (VIII)
Analogously to the preparation of the compound Va (oxidation with NaI0 4 ) sulfoxide VIii was prepared from VIla (0'5 g) in a 88% yield, m.p. 180-18ZoC, [0:]5 5 +13'0°(c 0'2, water). For C,H 1 5NOsS (237'3) calculated: 40'50% C, 6'37% H, 5'90% N; found: 40'71% C, 6'41% H, 5'95% N. R F values are given in Table 1 .
S-(J}-Methoxycarbonylethyl)homocysteine Sulfone (IX)
Oxidation of VIla (0'5 g) with performic acid afforded sulfone IX. a) To the suspension of Va (340 mg) in acetone (5 rot) 35% hydrogen bromide in acetic acid (2 rot) was added and after 5 min at room temperature the resultant solution was evaporated. After briefly drying (1 Torr) the residue was suspended in acetone (5 rot), the solvent was evaporated and this operation was repeated once more. The remnant was dissolved in water (10 ml) and the solution was passed through Amberlit IR-4B (OH--form, 25 ml) '5 g) was added and the pH was maintained at 7 by the addition of 2M-NaHC0 3 (21 ml) After 2 h no more NaHC0 3 is consumpted and the pH raises spontaneously. The mixture was acidified with IM-HCI to pH 3, extracted with ether (4 X 20 mI), ethereal layers were combined, washed with water and dried. After evaporation, the remnant was dissolved in benzene, dicyclohexylamine (1'6 ml) was added. the solution was diluted by the addition of light petroleum, cooled to O°C and crystals which separated were collected, dried and crystallized from ethyl acetate and light petroleum. To the solution of Va (385 mg) in water (l ml) 4M-NaOH (pH 8'5. 0'4 ml) was added and, under stirring and maintaining the pH at 8'5 (total 1'5 ml of 4M-NaOH). benzyloxycarbonyl chloride (0'5 ml) was added. After 2 h the consumption of NaOH ceased. The mixture was diluted by water (2 mI), extracted with ether, the aqueous layer was acidified to pH 3 with concentrated hydrochloric acid (0'5 ml) and the product was taken up in ethyl acetate. The organic layer was washed with water, dried and evaporated; the yield was 487 rng (81%) of an oil with R F 0·65_ (SI), 0-16 (S2), 0-58 (S3), 0-65 (S4); [aJI;' -30-3" (c 0-2, dimethylformamide). From a part of this oily product the dicyclohexylammonium salt was prepared, identical with the One prepared as under a) above.
The Splitting of the Protecting Groups in the Presence of Sulfoxide a) Amino acid was liberated from its dicyclohexylammonium salt (X) (100 mg) by means of 0·025M-H 2S04 • The oil, obtained by usual working up of the mixture, was dissolved in acetic acid (0'1 ml) and 35% HEr in acetic acid (0'2 ml) was added. After 15 min at room temperature the product was precipitated by the addition of ether. TLC analysis revealed the presence of 5% of sulfide. To the solution of the protected peptide Xla (4'5 g) in acetic acid (22'5 ml) 35% RBr in acetic acid (45 ml) was added. After 10 min at room temperature the mixture was diluted with ether (450 ml), the precipitate formed was triturated with ether, collected. dried and dissolved in water (100 ml). The aqueous solutions was passed through a column of Amberlite IR-4B (acetate form, 60 ml) and eluted with water. A part of the eluate was withdrawn for comparison with the product of the oxidation reaction. To the remaining eluate (270 ml) sodium periodate (2 g) was added and the mixture was stirred at room temperature for 2 h. The cooled (ocC) solution was transferred to a column of Dowex 50 (H + -cycle, 60 ml), the column was washed with water (Dec; negative reaction for iodate ions) and the product was eluted with 10% pyridine (OCC). The solution was taken to dryness, dissolved in a small amount of methanol, diluted with benzene and evaporated; this operation was repeated once more. After the last evaporation. the residue was dissolved in methanol. diluted with ether, and the oil which was obtained crystallized on standing (contrary to the sample of sulfide where an attempt at crystallization failed). 
SuIfoxide of 2-Nitrobenzenes u1feny Iaspar aginyI~S~(r~methoxycarbonyIpropyl)cysteinyl-proly1--leucyl-glyclne Amide (XIII)
To the solution of the tetrapeptide XII (3·2 g) in dimethylformamide (45 ml), Neethylpiperidine (0'4 mI) and 2,4.5-trichlorophcnyl ester of 2-nitrobenzenesulfcnylasparagine (3'6 g) were added. After standing at room temperature for 18 h a further base (0'6 ml) and active ester (l'8 g) were added. After 72 h. the mixture was evaporated. the residue was triturated with ether and crystals which formed were collected and washed with ether. The product is water soluble and therefore water washings must be avoided. Precipitation from a mixture of methanol. dimethylformamide and ether yielded 3'2 g (63%) of a chromatographically pure product with m.p. 176-179"C; R F 0·27 (SI), 0'17 (S2), 0'24 (S3), 0'55 (S4) and 0'41 (CHCI 3-methanol; 4: 1). The sample for analysis was reprecipitated in the same way, m.p. 183-186"C; [«]5 5 -82'9" (c 0'2. dimethylformamide). For C31H46NsOllS2.H20 (788'9) calculated: 47'20% C, 6'13% H. 14'20% N; found: 47'39% C, 6'53% H, 14'29% N. Amino-acid analysis: Asp 1'01. Pro I-DO. Gly 1'02. Leu 0'99, Cys(C 3H 6COOH) 0'50.
Sulfoxide of 2-NitrobenzenesulfenyJglutaminyl~asparaginyl~S~(r-methoxycarbonylpropyl)cys teinyl-prolyl-leucyl-glycine Amide (X/Va) To the solution of protected pentapeptide XUI (3'1 g) in dimethylformamidc (40 ml) 2M-HeI in ether (2 ml) was added. After 4 min at room temperature the solution was diluted withether Lebl, Barth, Jost : (200 ml), the precipitate was collected, washed with ether and dried. It was then dissolved in dimethylformamide (40 ml), the solution was alkalinized with Ncethylpiperidine (1'1 mI) and 2,4,5-trichlorophenyl ester of 2-nitrobenzenesulfenylglutamine (2·5 g) was added. After 12 h at room temperature a second portion of Neethylpiperidine (0-4 rot) was added and 32 It later the mixture was taken to dryness and the residue was triturated with ether. Precipitation from methanol and ether provided 4'1 g of a mixture of hexapeptide X/Va and Neethylpiperidine hydrochloride. A part of this mixture (0'5 g) was dissolved in water (20 rnI) and filtrated through a column of Amberlitc IR-4B (acetate form; 10 mI). The eluatewas evaporated, dissolved in benzene, taken to dryness and precipitated from a mixture of methanol, dimethylformamide and ether. The yield of chromatographically and electrophoretically pure product was 0·44 g (88%), b) To the solution of hexapeptide XIVa (180 mg) in water (25 ml) NaI0 4 (90 mg) was added. After 4 h at room temperature (the colour of the mixture disappeared) the solution was passed through a column of Dowex-50 (H+-cycle; 4 ml), the ion exchanger was washed with water and the product was eluted with 10% pyridine. The eluate was evaporated and the residue was precipitated from methanol and ether. The yield was 130 rug (87%) of a product of the same properties as had the compound prepared as under a) above.
To the solution of XI Vb (2,5 g ) in dimethylformamide (35 ml) Nehydroxysuccinlmide ester of z-nltrobenzenesulfenyllscleucine (2'3 g) and Ncethylpiperidine (250}JI and after 2 h 100 }JI) was added, After 70 h stirring at room temperature the mixture was evaporated, the residue was triturated with ether, the crystalline portion was collected and washed with ether, ethyl acetate, water, ethyl acetate and ether. The crystallization from dimethylformamide, methanol and ether yielded 2·67 g (82%) of the product with m.p. To the solution of heptapeptide XVa (2'0 g) in dimethylformamide (60 ml) 2M-Hel in ether (2'4 mI) was added. After 5 min at room temperature the mixture was diluted with ether (300 ml), the precipitate was collected. washed with ether and dried; R p 0'05 (81), 0-07 (82), 0'08 (83), 0'41 (84), E~5ro·42. The compound was dissolved in water (50 ml), the solution was alkalinized with IM-NaOH (6 ml, pH 12) and after 25 min the pH was brought to the value of 7 (5'7 ml of IM-Hel). The solution was cooled (DOC), transferred to a column of Dowex-50 (H+-cycle, 60 rot), the column was washed with water (O°C) and the product was eluted with 10% pyridine. Sulfoxide of Tyrosyl-isoleucyl-glutaminyI-asparaginy1~S-(y-carb oxypropyljcystelnyI-prol yl--leucyl-glycine Amide Lactam (Ia) a) To the solution of protected octapeptide XVI (500 mg) in dimethylformamide (15 ml) and pyridine (15 ml) was, under nitrogen, bisfp-nitrophenyljsulfite (1 g) added and after 6 h at room temperature a further sulfite (1 g). After 12 h another 0'5 g portion of sulfite was added and 5 h later the mixture was evaporated, the residue was triturated with ether, collected, dried and dissolved in dimethylfcrmamide (9 ml). To the solution 2M-HCI in ether (1 ml) was added and after 6 min at room temperature the mixture was diluted with ether (300 ml), the precipitate was collected, washed with ether and dissolved in dimethylformnmide (20 mf). This solution was added, at a rate of 5 mljh, to a mixture of pyridine (320 ml) and N-ethylpiperidine (I50 J1.1) under heating (50°C) and nitrogen bubbling. The mixture was stirred 2 h at 50"C, then 14 h at room temperature, taken to drynessand the residue was triturated with ether. The oily product was dissolved in trifluoroacetic acid (15 mI) and after 50 min at room temperature the mixture was diluted with toluene (15 ml) and evaporated. The residue was triturated with ether and the solid compound was dissolved in 25 ml of the upper phase of the solvent system 2-butanol-0·05% aqueous acetic acid, the filtered solution was placed in the second tube of the counter-current distribution machine and 150 transfers of the upper phase and 60 transfers of the lower phase were carried LebI, Barth; Jost : out. Three peaks with K = 0'14,0'60 and 1'30 were found. The first peak contained a ninhydrinpositive compound, the second one contained only a very small amount of peptide material and was not analysed. The third peak with K= 1'30 (tubes No 49-73) was concentrated to a small volume and Iyofilized. The yield was 130 rug (31%). A part of this product (60 mg) was dissolved in 3M acetic acid (2 ml) and transferred to a column of Bie-gel P-4. Lyofilisation of a peak of biologically active material (localised by OD 2 8 0 ) yielded qri-Z'mg of the product identical in all properties with the product obtained by oxidation. The sample for analysis was precipitated from methanol and ether, [~]fi5 _50'0°(c 0'12, water). For C44H67NllOt3S .
.3 H zO.CzH40Z (J ]04) calculated: 50'03% C, 7-02% H, 13-95% N; found: 49-83% C, 6'70% H, To the solution of deamino-f-carba-oxytocirr[ (Ie) (15 mg) in water (0'5 ml)sodium perledate (6'4 mg) was added. After 2 h at room temperature the mixture was diluted with 3r.1 acetic acid (1 ml) and transferred to a column of Bie-gel P-2 (100 X I ern) in 3M acetic acid. The product was localized by OD Z80 and Iyofilisation of the peak afforded 9·5 mg of the product. R F value are given in Table III. c) The solution of deamlno-J-carba-oxytocin'' (Ie) (15 mg} in methanol (0'2 ml) was left aside for 6 months at room temperature. TLC analysis revealed 30% of sulfoxide Ia.
Sulfone of Deamino-Iecarba-oxytocin (lb)
Deamino-l-carbu-oxytocin'' (Ie) (15 mg) was dissolved in a mixture (0'15 ml) of formic acid (4 ml) and 30% HzO z (0'3 ml), 30 min after the preparation of this mixture. After standing for 1 h at room temperature, the solution was freeze-dried, the lyofilisate was dissolved in water (0'5 ml) and again freeze-dried. After dissolving in 3M acetic acid the solution was transferred to a colu~n of Bio-gel P-2; the yield was 11 mg. The sample for analysis was precipitated from methanol and ether,[a]ft _65'5" (c 0'1, water). For C44H67N11014S.2 H zO.CzH40Z (1102) calculated: 50'13% C, 6'86% H, 13'98% N; found: 50'23% C, 6-57% H, 14'12% N. Amino-acid analysis: Asp 1'02, GIn 1'00, Pro 1-03, Gly 1-01,!Ie 0'98, Leu 1-02, Tyr 0-97, Cys(Oz)(C 3H._ .CaOH) 0'95 (for calculation the constant for Cys(C 3H6COOH) was used); no trace of Cys• .(C 3H.COOH) was found.
Sulfoxide of Deamino-fi-carba-oxytocin (Ie) To the solution of deamino-ri-carba-oxytocin" (If) (3'4 mg) in a mixture of water (200 Ill) and methanol (20 JlI) a solution of sodium periodate (l'5 mg) in water (10 Ill) was added. After 2 h standing at room temperature the mixture was worked up as described above; yield was 2'1 mg. TLC analysis proved that the product contained no sulfide If, cf. Table III . Amino-acid analysis: Asp 1'06, Glu l'OO,Pro 1'00, Gly 1'00, lie 0-97, Leu 1-04, Tyr 0-95, Hcy(C zH 4COOH) 0-51.
Sulfoxide of t-Carba-oxytocln (Id)
To the solution of f-carba-oxytocin't'' (Ig) (5 rng} in a mixture of water (300 ul) and methanol (20 J.1I) a solution of sodiumperiodate (2,4 mg) in water (10 Ill) was added. After 2 h standing. at room temperature the mixture was worked up as described for Ia above. The yield was 2-5 mg,
R p values are given in Table III Sulfoxides of Carba-Analogues of Oxytocin Deamino-J -carba-oxytocin (Ie) 
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To the suspension of sulfoxide Ia (Z mg) in acetone (ZOO Ill) 35% HBr in acetic acid (100 Jl1) was added. The obtained solution was after 12 min standing at room temperature evaporated, the residue was suspended in acetone (2 ml ) and evaporated again. The remnant was triturated with ether, dried, dissolved in 3M acetic acid and transferred to a column of Bie-gel pw2 in 3M acetic acid. The procedure yielded I'Z mg of a compound chromatographically identical with deernlno-t-carba-oxytocin, having 1790 LV./mg when tested on the isolated rat uterus.
Pharmacological Methods
The assay on the isolated rat uterus was carried out on strips of uterus of adult Wistar strain rats, under the influence of oestrogens. The strips were placed into the medium 3 9 which was bubbled through with 95% 02 -5% CO 2 at 30°C. Isometric contractions were recorded using a magnetoelectric transducerd"; oxytocin was used as a standard. The inhibitory effect of analogue Ib was measured by the shift of the dose-response curve. For the determination of the milk-ejectIng activity, lactating female rats (5-14 days after delivery) of the same strain were used. The assay was carried out as described in ref. 4 
